Making Medicines affordable.

News Room

Press Releases

Releases 2010Releases 2009Releases 2008 Releases 2007 Releases 2006 Releases 2005 Releases 2004 Releases 2003

Media Kit

Press Releases

2010

PRESS RELEASE | 3 March 2010

"If the patent system is not reformed in Europe, drug manufacturers will encounter increasing hurdles to competition and real innovation." This was the message delivered by Greg Perry, director general of the EGA, in his opening address to delegates at the 6th EGA legal affairs forum on 11 March 2010, in Munich, Germany. More...

PRESS RELEASE | 3 March 2010

“New controls of Active Pharmaceutical Ingredients (APIs) must be workable, effective and ensure continuous supply of all medicines”. This was the key message of Greg Perry director general of the European Generic medicines Association (EGA) at the round table hosted by MEP Judith Merkies and MEP Marisa Matias on “Effective Controls against Falsification in Active Pharmaceutical Ingredients and Excipients” in the European Parliament on 2 March. More...

PRESS RELEASE | 21 January 2010

Greg Perry, director general of the European Generic medicines Association (EGA) opened the 9th edition of the EGA Scientific and Regulatory Affairs Conference in London, by reiterating the association’s vision to create an improved European regulatory framework for generic and biosimilar medicines. More...

PRESS RELEASE | 20 January 2010

During the ongoing codecision procedure, policy makers must keep in mind the objectives of the European Commission pharmacovigilance legislative proposals which consist in strengthening, but also streamlining and rationalising, the Community pharmacovigilance system with a view to preventing unnecessary patient exposure to risks. This was the key message given by Suzette Kox, EGA Senior Director Scientific Affairs, at the EGA’s 3rd Pharmacovigilance Discussion Forum in London today. A number of national competent authorities and the European Consumers’ Organisation participated in the forum. More...

The EGA

“In an era when increasing demands are being made on Europe’s healthcare services, generic medicines provide a major benefit to society as they ensure patient access to quality, safe and effective medicines while reducing the cost of medicinal care.”

The EGA is the official representative body of the European generic pharmaceuticals industry, which is at the forefront of providing high-quality affordable medicines to millions of Europeans while stimulating competitiveness and innovation in the pharmaceutical sector.

The EGA represents over 500 companies and their subsidiaries from greater Europe, and over 120,000 jobs. Generic medicines save €25 billion each year for health care systems and patients.

For further information: